Figure 2From: Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusionChanges of arteriolar RBC velocity at baseline and during reperfusion in the group treated with saline (I/R) and those treated with abiciximab (AB), eptifibatide (EF), t-PA (tPA) and abiciximab plus t-PA (tAB) or eptifibatide plus t-PA (tEF), respectively. See text for details. Values are means ± SD, n = 20 experimental observations for each entry, *p < 0.05 I/R-tPA vs. baseline; °p < 0.05 AB, EF, tAB, and tEF vs. I/R and tPA; ** p < 0.05 tAB abd tEF vs.AB and EF.Back to article page